| Numurs | Nosaukums |
|---|---|
| NVD11R.14.4.2 | OMNIPAQUE 32,35 g/50 ml |
| NVD11R.14.4.20 | Visipaque 270 mg I/ml šķīdums injekcijām |
| NVD11R.14.4.21 | VISIPAQUE 275 g/500 ml |
| NVD11R.14.4.23 | Visipaque 320 mg I/ml šķīdums injekcijām |
| NVD11R.14.4.24 | Visipaque 320 mg I/ml šķīdums injekcijām |
| NVD11R.14.4.25 | Visipaque 320 mg I/ml šķīdums injekcijām, 500ml |
| NVD11R.14.4.27 | CLARISCAN 7,5 mmol/15 ml |
| NVD11R.14.4.29 | CLARISCAN 25 mmol/50 ml |
| NVD11R.14.4.3 | Omnipaque 300 mg I/ml šķīdums injekcijām, 100ml |
| NVD11R.14.4.31 | CLARISCAN 50 mmol/100 ml |
| NVD11R.14.4.32 | Gadovist 1.0 pilnšļirce /flakons 7.5ml N1 |
| NVD11R.14.4.33 | Gadovist 1.0 pilnšļirce/ flakons 15ml N1 |
| NVD11R.14.4.35 | Gadovist 1.0 65ml N10 |
| NVD11R.14.4.36 | Primovist sol.p/inj.10ml N1(pilnšl.) |
| NVD11R.14.4.37 | SonoVue |
| NVD11R.14.4.39 | PPROHANCE 0,5mmol/ml-15 ml šķīdums injekcijām |
| NVD11R.14.4.4 | OMNIPAQ.647(300)mg/ml200ml N10 |
| NVD11R.14.4.40 | PPROHANCE 0,5mmol/ml-20 ml šķīdums injekcijām |
| NVD11R.14.4.5 | OMNIPAQ.647(300)mg/ml 500ml N6 |
| NVD11R.14.4.6 | OMNIPAQUE 37,75 g/50 ml |